Therapeutic Antitumor Combination of a TLR4 Ligand With Other Treatments
Patent Cooperation Treaty
PCT/US17/019342
Filed on 2017-02-24
PCT/US17/019342
Filed on 2017-02-24
PSEUDOMONAS EXOTOXIN A WITH LESS IMMUNOGENIC B CELL EPITOPES
US Patent 10,111,927
Filed on 2017-04-17
Filed on 2017-04-17
A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1
Sweden
04814140.2
Filed on 2004-12-10
04814140.2
Filed on 2004-12-10
A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1
Norway
04814140.2
Filed on 2004-12-10
04814140.2
Filed on 2004-12-10
A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1
The Netherlands
04814140.2
Filed on 2004-12-10
04814140.2
Filed on 2004-12-10
A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1
Luxembourg
04814140.2
Filed on 2004-12-10
04814140.2
Filed on 2004-12-10
A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1
Ireland
04814140.2
Filed on 2004-12-10
04814140.2
Filed on 2004-12-10
A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1
Greece
04814140.2
Filed on 2004-12-10
04814140.2
Filed on 2004-12-10
A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1
United Kingdom
04814140.2
Filed on 2004-12-10
04814140.2
Filed on 2004-12-10